COHA Member, Dr. Susan VandeWoude Named Director of CSU One Health Institute
Dr. VandeWoude is a professor of comparative medicine as well as associate dean for research in CVMBS. Photo: William A. Cotton/CSU Photography
By Lauren Klamm
Dr. Susan VandeWoude, associate dean for research in the Colorado State University College of Veterinary Medicine and Biomedical Sciences, and member of the National Academy of Sciences, has been named the director of the CSU One Health Institute. She will assume full-time duties July 1, 2020, after completing a Fulbright scholarship award.VandeWoude will lead the institute, which is focused on examining interconnected problems in health, between humans, animals and the environment. Her new role will work to enhance interdisciplinary approaches to gain additional insights into the complex health relationships, said CSU Vice President for Research Alan Rudolph.“The One Health Institute explores the interfaces and relationships between animals, humans and the environment, recognizing the connectedness of the ecosystem when it comes to disease and other environmental perturbations,” Rudolph explained.
Research on viruses
Between research, teaching and veterinary medicine, VandeWoude has served in a variety of roles at CSU. She became a faculty member in the Department of Microbiology, Immunology, and Pathology in 1991, and served as director of Laboratory Animal Resources from 2007-11. VandeWoude is a professor of comparative medicine as well as associate dean for research in CVMBS.VandeWoude has specialized in studying immunodeficiency viruses affecting domestic and non-domestic felines that can leave animals vulnerable to other infections. Her discoveries are linked to both animal and ecological concerns and help illustrate the emergence and spread of viruses in humans. Her outstanding work in this area contributed to her election to the National Academy of Sciences in 2019.
About Sue VandeWoude
VandeWoude completed her bachelor of science at California Institute of Technology and her doctor of veterinary medicine degree at Virginia Maryland Regional College of Veterinary Medicine. After a brief time in clinical veterinary practice, she completed a post-doctoral fellowship in comparative medicine at Johns Hopkins University School of Medicine.Her post-doctoral research involved characterization of the viral agent associated with Borna Disease Agent. She joined Colorado State University in 1990 and obtained Diplomate status in the American College of Laboratory Animal Medicine in 1991.
About One Health Institute
The One Health Institute grew from initiatives led by Dr. Mark Stetter, dean of the College of Veterinary Medicine and Biomedical Sciences, with assistance from VandeWoude. When One Health activities expanded to other colleges, oversight transferred to the Office of the Vice President for Research. The institute began in 2015 when the Office of the Vice President for Research awarded a total of $360,000 in seed grants to jump-start six promising One Health research projects across campus.In April 2019, the initiative awarded four grants to teams exploring interrelationships of people, animals and the environment to solve important complex health problems in the Navajo Nation, the dairy industry, Colorado food systems and disease risk in Guatemala.“I am very excited to bring together and reinvigorate the CSU One Health community, reengage with local partners, collaborate with other CSU centers and institutes with health-related goals, and operationalize ongoing and new initiatives in One Health,” said VandeWoude.
The One Health Institute is housed in Johnson Hall.
It is with deep sadness and regret that we share with you the passing of our colleague, Dr. Kristy Richards…
Trailblazing lymphoma researcher Dr. Kristy Richards dies
Dr. Kristy Richards, a groundbreaking cancer researcher and associate professor of biomedical sciences at Cornell University College of Veterinary Medicine died on March 30 in New York City. She was 50.
Richards, an advocate for COHA and Cornell’s Clinical & Translational Science Center (CTSC), was known for her trailblazing interdisciplinary work treating cancer in dogs in hopes of discovering a therapy for humans. Her research included immunotherapy approaches, which employ the body’s own immune system to fight cancer cells.
“In addition to her many scientific and career accomplishments, Kristy had unbounded energy and an infectious passion for discovery,” said Dr. Lorin Warnick, the Austin O. Hooey Dean of the Cornell University College of Veterinary Medicine. “She was a wonderful citizen of the college and university. She was always willing to provide a supportive voice for our initiatives, and took great pride in the empowerment of others. Kristy’s passing is a tremendous loss to us personally and to the research field she pushed forward with great determination.”
Richards received her B.S. in biology (magna cum laude) from Cornell before attending Stanford University, where she earned a doctorate in 1997 and an M.D. in 2001. She did an internal medicine residency at Brigham and Women’s Hospital in Boston from 2001 to 2003, and completed a medical oncology fellowship at the MD Anderson Cancer Center in Houston, Texas, from 2003-07.
In 2007, she joined the faculty of the Department of Medicine at the University of North Carolina. She was hired in 2015 as an associate professor in the Department of Biomedical Sciences at Cornell’s College of Veterinary Medicine and held dual appointments at Cornell’s Ithaca campus and in the Division of Hematology/Medical Oncology at Weill Cornell Medicine.
Richards was a formal co-investigator on Cornell’s CTSC, spearheading a project entitled: “Improving experimental therapeutic development by incorporating studies in veterinary patients.” She also served an ambassador role, encouraging faculty to pursue CTSC funding. With COHA, she engaged in inter-institutional collaborative clinical trials and served as the lead faculty advisor for the Cornell Veterinary Biobank, where she also served as chair of the governance committee.
Richards was an author on nearly 60 original research publications. She served as a Leukemia and Lymphoma Society board member, North Carolina chapter, from 2010-2015, and until her death was on the Cancer and Leukemia Group B/Alliance for Clinical Oncology Trials Pharmacogenomics and Population’s Pharmacology Committee (since 2011) and Lymphoma Committee (since 2008).
She was also an active member of the American Society of Hematology and the American Association for Cancer Research. She served as a Progressive Assessment of Therapeutics program co-leader, and an academic editor for PLoS One and PeerJ.
Richards is survived by her parents, a sister, a brother, a nephew and two nieces.
Donations in Dr. Richard’s memory can be made to the CLEAR, National Center for Science Education, Doctors Without Borders, Pennsylvania’s Governor’s School for the Sciences, Corporation for Public Broadcasting, Cornell’s Comparative Cancer Biology Program-Lymphoma or the College of Veterinary Medicine Biobank.